FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

Vaccines and Related Biological Products Advisory Committee

horizontal rule

May 18, 2006 Meeting

Date and Time:

The meeting will be held on May 18, 2006; 9:00 a.m. to 4:45 p.m.

Location:

Hilton Hotel, Washington DC North/Gaithersburg, 620 Perry Parkway, Gaithersburg, MD 20877; 301-977-8900

Contact Persons:

Christine Walsh, R.N. or Denise Royster, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512391. Please call the Information Line for up-to-date information on this meeting.

Agenda:

The committee will hear presentations and make recommendations on the safety and efficacy of GARDASIL® (Human Papillomavirus [Types 6,11,16,18] Recombinant Vaccine) manufactured by Merck.

Oral Presentations:

Between approximately 1:30 and 2:30 p.m. oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before May 11, 2006.

May 19, 2006 Research Review Subcomittee of the Vaccines and Related Biological Products Advisory Committee

 

 
horizontal rule